Evidence map›Paper›PMID 32240416›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2020

Informing MS patients on treatment options: a consensus on the process of consent taking.

C Tortorella, C Solaro, P Annovazzi, L Boffa, M C Buscarinu, F Buttari, M Calabrese, P Cavalla, E Cocco, C Cordioli and 23 more

Abstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

C TortorellaDepartment of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy. carla.tortorella@gmail.com.
C SolaroDepartment of Rehabilitation, Mons L Novarese Hospital, Moncrivello, Italy.
P AnnovazziMultiple Sclerosis Center, ASST Valle Olona, PO di Gallarate, (VA), Italy.
L BoffaDepartment of Neurosciences, MS Center, Tor Vergata University, Rome, Italy.
M C BuscarinuDepartment of Neurosciences, Mental Health and Sensory Organs Sapienza University Rome, Rome, Italy.
F ButtariI.R.C.C.S. Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy.
M CalabreseNeurology B, Department of Neurosciences Biomedicine and Movements, University of Verona, Verona, Italy.
P CavallaMS Center (P.C.), City of Health & Science University Hospital, Turin, Italy.
E CoccoDepartment Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
C CordioliMultiple Sclerosis Center, ospedale di Montichiari, Spedali Civili di Brescia, Montichiari, Italy.
G De LucaNeurology Clinic, Multiple Sclerosis Center SS. Annunziata Hospital, Chieti, Italy.
M Di FilippoClinica Neurologica, Dipartimento di Medicina, Università di Perugia, Perugia, Italy.
R FantozziI.R.C.C.S. Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy.
D FerraroDepartment of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
A GajofattoDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
A GalloDepartment of Medical, Surgical, Neurological, Metabolic and Aging Science, University of Campania, Naples, Italy.
R LanzilloMultiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
A LaroniDepartment of Neuroscience, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research, University of Genova, Genoa, Italy.
S Lo FermoClinica Neurologica A.O.U. Policlinico-Vittorio Emanuele Catania, Catania, Italy.
S MalucchiNeurologia 2-CRESM, AOU San Luigi Gonzaga, Orbassano, Italy.
G T ManiscalcoDepartment of Neurology and Stroke Unit, "A. Cardarelli Hospital", Naples, Italy.
M MocciaMultiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Naples, Italy.
V NocitiIstituto di Neurologia, Fondazione Policlinico Universitario 'A Gemelli' IRCCS, Rome, Italy.
D PaolicelliDepartment of Basic Medical Sciences, Neurosciences, and Sense Organs, University of Bari, Bari, Italy.
I PesciOspedale di Vaio, Centro SM, Fidenza, Parma, Italy.
L ProsperiniDepartment of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
P RagoneseDepartment of Biomedicine, Neurosciences and Advanced Diagnostic, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Palermo, Italy.
V TomassiniDepartment of Neurosciences, Imaging and Clinical Sciences, School of Medicine, Institute for Advanced Biomedical Technologies (ITAB), University of Chieti-Pescara "G. d'Annunzio, Chieti, Italy.
V L A Torri ClericiNeuro-immunology and Neuromuscolar Diseases Unit, IRCCS Foundation Carlo Besta Neurological Institute, Milan, Italy.
M RodegherDepartment of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
M GherardiSC Medicina Legale AUSL Valle D'Aosta, Aosta, Italy.
C GasperiniDepartment of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.
RIReMS Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient's empowerment in the decision-making process.

aimsThe aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice.

resultsThe new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.

Indexed as

Informed ConsentMultiple SclerosisHumansItalyPhysician-Patient RelationsDisease modifying treatmentInformed consentMultiple sclerosis

Identifiers

PMID32240416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.